Sensus Healthcare, Inc.
NASDAQ:SRTSMedical - Devices
+$0.09 today
- Market cap
- $53.01M
- Beta
- 1.09
- P/E (TTM)
- -6.5
- EPS (TTM)
- -$0.47
Volume 0.08M
Average 0.06M
SRTS Interest Income
Income earned on cash, deposits, and investments held by the company.
Sensus Healthcare, Inc.NASDAQ: SRTS
Interest Income · Q1 FY2026 · quarter ended Mar 2026
Interest income declines year over year
Q1 FY2026 interest income of $125K fell 32.1% year over year, behind the -7.9% change in trailing-twelve-month interest income. Sequentially, it fell 19.9% from the prior quarter. Over 3 fiscal years it compounded at +21.4% a year.
Context
- Interest income amounted to 2.5% of revenue in FY2025, up 0.3 pp from a year earlier.
- Interest income increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -32.1% toward the trailing-twelve-month pace of -7.9%.
Sources:Income StatementText generated from reported figures; not investment advice.
Interest Income history
USD · from the income statement
- Latest · FY2025
- 683K USD
- Year-over-year change
- -26.7%
- 4-year CAGR
- +329.9%
| Period | Period end | Interest Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 683K | -26.7% |
| FY2024 | 2024-12-31 | 932K | -6.0% |
| FY2023 | 2023-12-31 | 992K | +159.7% |
| FY2022 | 2022-12-31 | 382K | +19000.0% |
| FY2021 | 2021-12-31 | 2K | — |
Interest Income vs competitors
How SRTS compares with its peers on the latest reported figures
- SRTS's LTM Mar 2026 interest income of $831K is the 3rd highest of the 6 companies compared; the peer median is $0.
- Its year-over-year change of -7.9% is the highest of 4, against a peer median of -63.4%.
- Interest income amounts to 3.7% of revenue for SRTS, versus a peer median of 0.8%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $6.94M | -43.0% | +34.9% | — | |
| LTM Mar 2026 | $2.28M | -63.4% | +5.5% | 1.5% | |
| LTM Mar 2026 | $831K | -7.9% | +21.4% | 3.7% | |
BDMDBaird Medical Investment Holdings Limited | FY2025 | $0 | -100.0% | — | 0.0% |
| LTM Jun 2026 | $0 | — | — | 0.0% | |
MDAISpectral AI, Inc. | LTM Mar 2026 | -$547K | — | — | 3.3% |
| Peer median (excluding SRTS) | $0 | -63.4% | +20.2% | 0.8% | |
Competitors are the stored peer set for SRTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 27.04M | 44.53M | 24.41M | 41.81M | 27.48M |
| Cost of Revenue | 10.05M | 14.9M | 10.35M | 17.38M | 15.62M |
| Gross Profit | 16.99M | 29.63M | 14.06M | 24.43M | 11.87M |
| Gross Margin | 62.8% | 66.5% | 57.6% | 58.4% | 43.2% |
| Research & Development | 3.44M | 3.46M | 3.68M | 4.22M | 7.78M |
| Selling, General & Admin | 9.43M | 11.34M | 10.76M | 12.13M | 14.4M |
| Operating Expenses | 12.87M | 14.8M | 14.44M | 16.34M | 22.17M |
| Depreciation & Amortization | 613K | 509K | 461K | 432K | 386K |
| EBITDA | 4.73M | 28.5M | 1.11M | 9.45M | (9.24M) |
| EBITDA Margin | 17.5% | 64.0% | 4.6% | 22.6% | -33.6% |
| Operating Income | 4.12M | 14.83M | (382K) | 8.09M | (10.31M) |
| Operating Margin | 15.2% | 33.3% | -1.6% | 19.4% | -37.5% |
| Interest Income | 2K | 382K | 992K | 932K | 683K |
| Interest Expense | 1K | 2K | 0 | 0 | 0 |
| Other Income / Expenses | (1K) | 13.16M | 1.03M | 932K | 683K |
| Income Before Tax | 4.12M | 27.99M | 652K | 9.02M | (9.62M) |
| Pre-Tax Margin | 15.2% | 62.9% | 2.7% | 21.6% | -35.0% |
| Income Tax Expense | 0 | 3.75M | 167K | 2.38M | (1.91M) |
| Net Income | 4.12M | 24.24M | 485K | 6.65M | (7.72M) |
| Net Margin | 15.2% | 54.4% | 2.0% | 15.9% | -28.1% |
| EPS (Basic) | 0.25 | 1.47 | 0.03 | 0.41 | (0.47) |
| EPS (Diluted) | 0.25 | 1.46 | 0.03 | 0.41 | (0.47) |
| Weighted Avg Shares | 16.48M | 16.48M | 16.26M | 16.31M | 16.33M |
| Weighted Avg Shares (Diluted) | 16.5M | 16.62M | 16.27M | 16.36M | 16.33M |
Sensus Healthcare, Inc.
NASDAQ:SRTS
Intrinsic Alpha fair value
Locked
Current Price
$3.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.